Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro

References

• Andriessen TM, Jacobs B, Vos PE. Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 2010;14:2381–92.
   PubMed Web of Science ®Google Scholar
• Lv Q, Fan X, Xu G, et al. Intranasal delivery of nerve growth factor attenuates aquaporins-4-induced edema following traumatic brain injury in rats. Brain Res 2013;1493:80–9.
   PubMed Web of Science ®Google Scholar
• Tian L, Guo R, Yue X, et al. Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats. Brain Res 2012;1440:47–55.
   PubMed Web of Science ®Google Scholar
• Beglova N, Maliartchouk S, Ekiel I, et al. Design and solution structure of functional peptide mimetics of nerve growth factor. J Med Chem 2000;43:3530–40.
   PubMedGoogle Scholar
• Estenne-Bouhtou G, Kullander K, Karlsson M, et al. Design, synthesis, tandem mass spectrometric sequencing and biological activity of NGF mimetics. Int J Pept Protein Res 1996;48:337–46.
   PubMedGoogle Scholar
• Peleshok J, Saragovi HU. Functional mimetics of neurotrophins and their receptors. Biochem Soc Trans 2006;34:612–7.
   PubMedGoogle Scholar
• Scarpi D, Cirelli D, Matrone C, et al. Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity. Cell Death Dis 2012;3:e389.
   Google Scholar
• Seredenin SB, Gudasheva TA. Dipeptide mimetics of NAG BDNF. Byull. Izobr 2011;No. 3: Patent of RF No. 2410392.
   Google Scholar
• Gudasheva TA, Antipova TA, Seredenin SB. Novel low-molecular-weight mimetics of the nerve growth factor. Dokl Biochem Biophys 2010;434:262–5.
   PubMedGoogle Scholar
• Antipova TA, Gudasheva TA, Seredenin SB. In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic. Bull Exp Biol Med 2011;150:607–9.
   PubMedGoogle Scholar
• Seredenin SB, Romanova GA, Gudasheva TA, et al. Neuroprotective and antiamnestic effect of nerve growth factor dipeptide mimetic GK-2 in experimental ischemic infarction of brain cortex. Bull Exp Biol Med 2011;150:432–5.
   PubMedGoogle Scholar
• Seredenin SB, Silachev DN, Gudasheva TA, et al. Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin. Bull Exp Biol Med 2011;151:584–7.
   PubMedGoogle Scholar
• Isaev NK, Novikova SV, Stelmashook EV, et al. Mitochondria-targeted plastoquinone antioxidant SkQR1 decreases trauma-induced neurological deficit in rat. Biochemistry (Mosc) 2012;77:996–9.
   PubMed Web of Science ®Google Scholar
• Feeney DM, Boyeson MG, Linn RT, et al. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981;211:67–77.
   PubMed Web of Science ®Google Scholar
• Hicks SP, D’Amato CJ. Locating corticospinal neurons by retrograde axonal transport of horseradish peroxidase. Exp Neurol 1977;56:410–20.
   PubMed Web of Science ®Google Scholar
• De Ryck M, Van Reempts J, Borgers M, et al. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989;20:1383–90.
   PubMed Web of Science ®Google Scholar
• Jolkkonen J, Puurunen K, Rantakumi S. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur J Pharmacol 2000;400:211–9.
   PubMed Web of Science ®Google Scholar
• Stelmashook EV, Novikova SV, Isaev NK. Glutamine effect on cultured granule neuron death induced by glucose deprivation and chemical hypoxia. Biochemistry (Mosc) 2010;75:1039–44.
   PubMed Web of Science ®Google Scholar
• Neet, KE, Mahapatra, S, Mehta HM. Selectivity of Cell Signaling in the Neuronal Response Based on NGF Mutations and Peptidomimetics. In: De La Monte S, ed. Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets. Croatia: In Tech Janeza Trdine 9, 51000 Rijeka, 2011: 244–272.
   Google Scholar
• Maliartchouk S, Feng Y, Ivanisevic L, et al. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol 2000;57:385–91.
   PubMed Web of Science ®Google Scholar
• Massa SM, Xie Y, Longo FM. Alzheimer's therapeutics: neurotrophin small molecule mimetics. J Mol Neurosci 2002;19:107–11.
   PubMedGoogle Scholar
• Colangelo AM, Bianco MR, Vitagliano L, et al. A new nerve growth factor-mimetic peptide active on neuropathic pain in rats. J Neurosci 2008;28:2698–709.
   PubMedGoogle Scholar
• Bruno MA, Clarke PB, Seltzer A, et al. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J Neurosci 2004;24:8009–18.
   PubMedGoogle Scholar
• Povarnina PY, Vorontsova ON, Gudasheva TA, et al. Original nerve growth factor mimetic dipeptide GK-2 restores impaired cognitive functions in rat models of Alzheimer's disease. Acta Naturae 2013;5:84–91.
   PubMedGoogle Scholar
• Levi-Montalcini R, Aloe L. Differentiating effects of murine nerve growth factor in the peripheral and central nervous systems of Xenopus laevis tadpoles. Proc Natl Acad Sci USA 1985;82:7111–5.
   PubMed Web of Science ®Google Scholar
• Markova EG, Isaev NK. Effects of nerve growth factor on the development of the dendritic system of cholinergic neurons in dissociated culture of the rat septum. Biull Eksp Biol Med 1992;113:318–20.
   PubMedGoogle Scholar
• Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217–81.
   PubMed Web of Science ®Google Scholar
• Gudasheva TA, Povarnina PYu, Antipova TA, Seredenin SB. A novel dimeric dipeptide mimetic of the nerve growth factor exhibits pharmacological effects upon systemic administration and has no side effects accompanying the neurotrophin treatment. Neurosci Med 2014;5:101–8.
   Google Scholar
• Cheng G, Kong RH, Zhang LM, Zhang JN. Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol 2012;167:699–719.
   PubMed Web of Science ®Google Scholar
• Song SX, Gao JL, Wang KJ, et al. Attenuation of brain edema and spatial learning deficits by the inhibition of NADPH oxidase activity using apocynin following diffuse traumatic brain injury in rats. Mol Med Rep 2013;7:327–31.
   PubMed Web of Science ®Google Scholar
• Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 2010;1802:92–9.
   PubMed Web of Science ®Google Scholar
• Plotnikov EY, Silachev DN, Chupyrkina AA, et al. New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties. Biochemistry (Mosc) 2010;75:145–50.
   PubMed Web of Science ®Google Scholar